D. M. Veine

发表

Two modes of catalysis have evolved

R. Schirmer, K. Becker, Pan-Fen Wang, 2000 .

Formation and properties of mixed disulfides between thioredoxin reductase from Escherichia coli and thioredoxin: Evidence that cysteine‐138 functions to initiate dithiol‐disulfide interchange and to accept the reducing equivalent from reduced flavin

P. Wang, C. Williams, S. Mulrooney, 1998, Protein science : a publication of the Protein Society.

Role of α(5)β(1) Integrin Up-regulation in Radiation-Induced Invasion by Human Pancreatic Cancer Cells.

D. Livant, T. Williams, E. Ben-Josef, 2011, Translational oncology.

The PHSCN dendrimer as a more potent inhibitor of human breast cancer cell invasion, extravasation, and lung colony formation

D. Livant, D. M. Veine, H. Yao, 2010, Breast Cancer Research and Treatment.

Therapeutic inhibition of breast cancer bone metastasis progression and lung colonization: breaking the vicious cycle by targeting α5β1 integrin

D. Livant, D. M. Veine, H. Yao, 2016, Breast Cancer Research and Treatment.

A d-amino acid containing peptide as a potent, noncovalent inhibitor of α5β1 integrin in human prostate cancer invasion and lung colonization

D. Livant, D. M. Veine, D. Stafford, 2014, Clinical & Experimental Metastasis.

Invasion by Human Pancreatic Cancer Cells 1

D. Livant, T. Williams, E. Ben-Josef, 2011 .

A stable mixed disulfide between thioredoxin reductase and its substrate, thioredoxin: preparation and characterization.

P. Wang, C. Williams, S. Ahn, 1996, Biochemistry.

Mechanism-based inactivation of thioredoxin reductase from Plasmodium falciparum by Mannich bases. Implication for cytotoxicity.

G. L. Kenyon, R. Schirmer, K. Becker, 2003, Biochemistry.

Thioredoxin reductase two modes of catalysis have evolved.

R. Schirmer, K. Becker, S. Müller, 2000, European journal of biochemistry.

Increased potency of the PHSCN dendrimer as an inhibitor of human prostate cancer cell invasion, extravasation, and lung colony formation

D. Livant, D. M. Veine, H. Yao, 2010, Clinical & Experimental Metastasis.

Crystal structure of a phosphoinositide phosphatase, MTMR2: insights into myotubular myopathy and Charcot-Marie-Tooth syndrome.

J. Dixon, J. Stuckey, G. Taylor, 2003, Molecular cell.

Validated MALDI-TOF/TOF mass spectra for protein standards

Maureen Kachman, Philip C Andrews, Jayson A Falkner, 2007, Journal of the American Society for Mass Spectrometry.

Redox potentials for yeast, Escherichia coli and human glutathione reductase relative to the NAD+/NADH redox couple: enzyme forms active in catalysis.

C. Williams, L. Arscott, D. M. Veine, 1998, Biochemistry.

Thioredoxin reductase from Escherichia coli: Evidence of restriction to a single conformation upon formation of a crosslink between engineered cysteines

D. M. Veine, K. Ohnishi, C. Williams, 1998, Protein science : a publication of the Protein Society.

Mixed disulfide with glutathione as an intermediate in the reaction catalyzed by glutathione reductase from yeast and as a major form of the enzyme in the cell.

C. Williams, L. Arscott, D. M. Veine, 2000, Biochemistry.

A d-amino acid containing peptide as a potent, noncovalent inhibitor of α5β1 integrin in human prostate cancer invasion and lung colonization

D. Livant, D. M. Veine, H. Yao, 2014, Clinical and Experimental Metastasis.